CIPLA has been approved by SAHPRA to produce vital medicines in its recently refurbished plant in Benoni, Gauteng. Being fully compliant with all quality and regulatory requirements, the facility is running at full capacity to ensure continuous supply of OTC medication.

The improvements at CIPLA include the construction of a new granulation suite with a new Glatt Integrated Batch Granulation Line, among others, to increase capacity, improve safety and drive efficiencies.

Read the full article in the current P&C REVIEW issue or learn more about Glatt’s Granulation Lines.